PACB.US Pacific Biosciences of California

Healthcare Life Sciences Tools & Services USA Stocks
1.96 USD
Close of Nov 15, 2026
1.07 3.44
Market cap
USD 612M
P/E
-
P/B
170.66x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PACB.US undervalued?

Graham number

The Graham number of Pacific Biosciences of California cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pacific Biosciences of California fundamental analysis

No fundamental analysis for Pacific Biosciences of California yet.

Pacific Biosciences of California stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pacific Biosciences of California

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, b…

Full company profile